Premier Biomedical (BIEI) Short Interest Ratio & Short Volume → The system that called 2023’s top 7 stocks is at it again… (From WealthPress) (Ad) Free BIEI Stock Alerts $0.0014 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsSEC FilingsStock AnalysisChartFinancialsSEC Filings Premier Biomedical Short Interest DataCurrent Short Volume8,200 sharesPrevious Short Volume0 sharesChange Vs. Previous Month+∞Dollar Volume Sold Short$4.92Short Interest Ratio / Days to Cover0.0Last Record DateAugust 31, 2023Today's Trading Volume672,900 sharesAverage Trading Volume1,747,716 sharesToday's Volume Vs. Average39% Short Selling Premier Biomedical ? Sign up to receive the latest short interest report for Premier Biomedical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIEI Short Interest Over TimeBIEI Days to Cover Over TimeBIEI Percentage of Float Shorted Over Time Ad WealthPressThe system that called 2023’s top 7 stocks is at it again…Look 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! Premier Biomedical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 8/31/20238,200 shares $4.92 No ChangeN/A0 $0.00 3/15/20237,000 shares $11.20 No ChangeN/A0 $0.00 2/15/202342,200 shares $88.62 +13.4%N/A0 $0.00 1/31/202337,200 shares $200.88 -58.0%N/A0 $0.01 1/15/202388,600 shares $283.52 +65.0%N/A0 $0.00 12/30/202253,700 shares $236.28 -42.1%N/A0 $0.00 Get the Latest News and Ratings for BIEI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Premier Biomedical and its competitors with MarketBeat's FREE daily newsletter. 12/15/202292,800 shares $148.48 -77.5%N/A0 $0.00 11/30/2022412,400 shares $989.76 +489.1%N/A0 $0.00 11/15/202270,000 shares $105.00 +4,566.7%N/A0 $0.00 10/31/20221,500 shares $2.55 -25.0%N/A0 $0.00 10/15/20222,000 shares $2.60 No ChangeN/A0 $0.00 9/30/20222,000 shares $3.00 No ChangeN/A0 $0.00 9/15/20222,000 shares $3.00 No ChangeN/A0 $0.00 8/31/20222,000 shares $3.60 No ChangeN/A0 $0.00 7/31/20224,000 shares $6.80 No ChangeN/A0 $0.00 6/30/202216,600 shares $44.82 No ChangeN/A0 $0.00 4/15/202218,400 shares $31.28 -38.7%N/A0 $0.00 3/31/202230,000 shares $45.00 No ChangeN/A0 $0.00 2/15/20227,700 shares $16.17 No ChangeN/A0 $0.00 12/31/2021100 shares $0.34 No ChangeN/A0 $0.00 12/15/2021100 shares $0.27 No ChangeN/A0 $0.00 11/30/2021100 shares $0.28 No ChangeN/A0 $0.00 11/15/2021100 shares $0.41 No ChangeN/A0 $0.00 10/29/2021100 shares $0.46 -99.6%N/A0 $0.00 10/15/202125,800 shares $154.80 +200.0%N/A0 $0.01 9/30/20218,600 shares $46.44 -97.5%N/A0 $0.01 9/15/2021342,600 shares $1,027.80 No ChangeN/A0 $0.00 6/15/202137,800 shares $68.04 No ChangeN/A0 $0.00 3/15/202144,800 shares $120.96 No ChangeN/A0 $0.00 2/12/202175,600 shares $279.72 No ChangeN/A0 $0.00 1/15/2021367,200 shares $550.80 +4,930.1%N/A0 $0.00 12/31/202026,300 shares $28.93 -92.8%N/A0 $0.00 12/15/2020367,200 shares $385.56 +4,930.1%N/A0 $0.00 11/30/20207,300 shares $7.30 No ChangeN/A0 $0.00 10/15/202040,300 shares $52.39 +122.7%N/A0 $0.00 9/30/202018,100 shares $16.29 No ChangeN/A0 $0.00 8/31/202063,700 shares $57.33 +2.9%N/A0 $0.00 8/14/202061,900 shares $61.90 -40.6%N/A0 $0.00 7/31/2020104,200 shares $104.20 No ChangeN/A0 $0.00 5/15/202059,700 shares $107.46 No ChangeN/A0 $0.00Thousands of investors use this no cost solution | Do you? (Ad)In today’s volatile markets we are all looking for the edge. But imagine tapping into a world where every investment move has the potential to be ahead of the curve. Most investors have heard of the publication Insider Financial. For nearly a decade, they've unlocked doors to opportunities tucked away from the public eye, guiding over a million investors with well researched information before it hits the mainstream media.Simply tap here now to subscribe and start getting "Insider Financial Advantage" BIEI Short Interest - Frequently Asked Questions What is Premier Biomedical's current short interest? Short interest is the volume of Premier Biomedical shares that have been sold short but have not yet been covered or closed out. As of August 31st, investors have sold 8,200 shares of BIEI short. Learn More on Premier Biomedical's current short interest. Is Premier Biomedical's short interest increasing or decreasing? Premier Biomedical saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 8,200 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.69 billion), Canadian Natural Resources Limited ($3.67 billion), T-Mobile US, Inc. ($3.56 billion), Suncor Energy Inc. ($3.20 billion), Occidental Petroleum Co. ($3.19 billion), Celsius Holdings, Inc. ($2.09 billion), Tractor Supply ($2.08 billion), Moderna, Inc. ($2.04 billion), Royal Caribbean Cruises Ltd. ($2.00 billion), and Rivian Automotive, Inc. ($1.96 billion). View all of the most shorted stocks. What does it mean to sell short Premier Biomedical stock? Short selling BIEI is an investing strategy that aims to generate trading profit from Premier Biomedical as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Premier Biomedical? A short squeeze for Premier Biomedical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIEI, which in turn drives the price of the stock up even further. How often is Premier Biomedical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIEI, twice per month. The most recent reporting period available is August, 31 2023. More Short Interest Resources from MarketBeat Related Companies: TGIFF Short Squeeze CATV Short Squeeze FFNTF Short Squeeze ABSCF Short Squeeze ACRDF Short Squeeze ACRHF Short Squeeze ALEAF Short Squeeze LBTSF Short Squeeze ALVOW Short Squeeze ERBB Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BIEI) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe #1 Crypto for 2024InvestorPlace